drugset / Trial / NCT07502417

A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

NCT07502417

Phase 1 Active not recruiting 15 enrolled AbbVie
NaSingle-groupOpen-labelBasic science

Summary

The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.

Timeline

Start
2026-03-27
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-722 Unknown Oral
Subject Levonorgestrel Small molecule Oral
Subject ethinyl estradiol Small molecule Oral

Indications

No indication recorded.